EPOR and cancer: The average frequency of EPOR alterations in pan-cancer was only 1.9%, but we unexpectedly found that EPOR gene alterations in pan-cancer prolonged DFS in patients (p = 8.53e-4) and that the frequency of EPOR alterations in OV was higher, at around 8%.